Commit To Buy Kymera Therapeutics At $35, Earn 18.3% Using Options
August 09, 2024 at 11:35 AM EDT
Investors considering a purchase of Kymera Therapeutics Inc (KYMR) shares, but cautious about paying the going market price of $42.44/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December 2025 put at the $35 strike, which has a bid at the time of this writing of $6.40..